FDA Authorizes Novel Clinical Trial Exploring Artery-Delivered Stem Cells for Knee Osteoarthritis
October 19, 2026
October 19, 2026
MIAMI, Florida, Oct. 19 -- The University of Miami Miller School of Medicine posted the following news:
* * *
FDA Authorizes Novel Clinical Trial Exploring Artery-Delivered Stem Cells for Knee Osteoarthritis
*
University of Miami Miller School of Medicine researchers are preparing to launch an innovative clinical trial that will investigate whether delivering stem cells through arteries supplying the knee can reduce pain and improve function an . . .
* * *
FDA Authorizes Novel Clinical Trial Exploring Artery-Delivered Stem Cells for Knee Osteoarthritis
*
University of Miami Miller School of Medicine researchers are preparing to launch an innovative clinical trial that will investigate whether delivering stem cells through arteries supplying the knee can reduce pain and improve function an . . .